Actavis now markets over 200 hospital products, a number that is rising rapidly, with around 650 applications pending worldwide for injectable medicines. In addition is an ambitious development pipeline with around 47 further new hospitals applications expected to be submitted during 2011/12.
In addition to oncology medicines, Actavis also markets a growing range of anti-infectives, local anaesthetics and analgesics.
Actavis’ hospital portfolio includes a comprehensive oncology range comprising over 30 molecules. These products are currently sold in markets all over the globe including the EU, US and Japan.
In addition to its own label pharmaceuticals, Actavis produces a range of oncology and non oncology injectable products for a range of commercial clients. These include branded companies such Pfizer and many of the leading generic houses, thus allowing other companies to take advantage of our manufacturing pedigree and scale.
You may already be using Actavis produced products without even knowing it.
Safe, reliable products
At Actavis, we are passionate about offering our customers access to one of the widest ranges of high quality, affordable hospital pharmaceuticals in the world, access to value that supports the choice of hospitals to work with newer medicines. At the same time we strive to make our products safer, easier to use and more reliable to source than other offerings.
At Actavis, we are passionate about the flexible design of our supply chain, holding bulk stocks of near-finished injectable products, which can be finalised quickly and efficiently for different markets. This design minimises our lead times, whilst maximising our responsiveness, reassuring for anyone who has experienced stock-out situations.
At Actavis, we are passionate about active protection and safe packaging designs, increasing safety of hospital pharmacists, clinicians and patients.
Supply on demand
Actavis has a robust supply chain that is more flexible than many of our competitors’.
We hold bulk supplies of undifferentiated, near-finished goods which can then be finalised quickly and efficiently for different markets – especially reassuring for anyone who has
experienced stock-out situations.
As a relative newcomer to the field of hospital medicines, we have had the advantage of being able to design an appropriate supply chain from scratch, unlike more mature incumbents. Reduced lead times, enhanced flexibility and improved customer service are among the factors contributing to the growth of Actavis in the hospital sector.
Active protection
Actavis is targeting the safety of clinicians and patients in a variety of ways, all of which play important roles in reducing error and wastage, whilst increasing efficiency.
Caring for the environment
Actavis is committed to protecting the environment and this is demonstrated by tangible actions not just words.
Download Actavis hospital brochure (PDF, 285kb)
Download Actavis EHS brochure (PDF, 462kb)